87 results
Page 2 of 5
6-K
EX-99.2
66xvfdw
29 Nov 22
Current report (foreign)
4:58pm
6-K/A
EX-99.2
a0qm 69d860f
12 Oct 22
Financial Statements for the years ended Report of Independent Registered Public Accounting Firm
5:45pm
6-K/A
EX-99.3
qx6wc0oebj1ej
12 Oct 22
Financial Statements for the years ended Report of Independent Registered Public Accounting Firm
5:45pm
6-K/A
EX-99.1
0yhyz3m44 s79mn3sja
12 Oct 22
Financial Statements for the years ended Report of Independent Registered Public Accounting Firm
5:45pm
6-K
EX-99.1
hfth3qq
7 Oct 22
Notice of Annual General Meeting
3:06pm
6-K
EX-99.2
h2hymi dt2mapo3mftzy
29 Aug 22
Current report (foreign)
4:00pm
424B5
gk4ax7vpwzvig ox
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-2.1
pfcupg903ys7quh
19 Jul 22
Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform
9:01am
6-K
EX-2.1
rse2a6xucbjdqhg
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-10.3
s7unvk1q5y
8 Jul 22
Current report (foreign)
8:58am
20-F/A
eeooerclq0o5h 4f
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.2
j86yh
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
f3e3ln1n
23 Nov 21
Current report (foreign)
4:30pm